UK Biotech Series A Funding Rounds 2026
Every UK Series A Biotech funding round filed in 2026, sourced direct from Companies House filings. Updated weekly.
UK Biotech Series A Funding Rounds 2026
| Company | Raised | Round | Date |
|---|---|---|---|
| Loqus23 Therapeutics | £15.0M | Series A | 2026/06/02 |
| Antiverse | £3.0M | Series A | 2026/05/28 |
| Camgene Therapeutics | £260k | Series A | 2026/05/17 |
| Cytospire Therapeutics | £3.4M | Series A | 2026/05/15 |
| Immutrin | £19.5M | Series A | 2026/05/12 |
| Draig Therapeutics | £34.6M | Series A | 2026/05/11 |
| Rivan Industries | £17.6M | Series A | 2026/05/07 |
| Resurrect Bio | £1.6M | Series A | 2026/04/27 |
| Fluidic Sciences | £3.0M | Series A | 2026/03/27 |
| Fermentation Technologies | £2.5M | Series A | 2026/03/26 |
| Accession Therapeutics | £5.7M | Series A | 2026/03/26 |
| Presentient Technologies | £427k | Series A | 2026/03/26 |
| Recircle | £625k | Series A | 2026/03/24 |